As of 18 Nov 2024, Alnylam Pharmaceuticals net assets is $-220.64M, an increase of 39.45% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Alnylam Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Year | Net assets | Change |
---|---|---|
2023 | $-220.64M | 39.45% |
2022 | $-158.22M | -126.90% |
2021 | $588.20M | -42.12% |
2020 | $1.02B | -29.36% |
2019 | $1.44B | -150.07% |
2018 | $-2.87B | - |